Beyond function: supervised exercise therapy may target inflammatory gene expression in patients with symptomatic...

Area of Science:

• Cardiovascular Medicine
• Exercise Physiology
• Molecular Biology

Background:

• Supervised exercise therapy (SET) is a primary treatment for symptomatic peripheral artery disease (PAD).
• The effects of SET on inflammation and its link to functional improvements in PAD are not well understood.

Purpose of the Study:

• To investigate the impact of a 12-week SET program on inflammatory gene expression in patients with symptomatic PAD.
• To explore the relationship between changes in inflammatory markers and functional outcomes after SET.

Main Methods:

• A prospective, single-arm study involving 51 patients with symptomatic PAD.
• Assessed limb perfusion, walking ability (6-minute walking distance), and muscle power pre- and post-SET.
• Measured inflammatory gene expression (PMN-elastase, MPO, MMP-9, NGAL, PAD4) in peripheral blood mononuclear cells using real-time quantitative PCR.

Main Results:

• SET significantly decreased mRNA expression of PMN-elastase and MPO.
• Trends toward reduction were observed for MMP-9, NGAL, and PAD4.
• Reductions in PMN-elastase and MMP-9 were significant in both SET responders and non-responders.

Conclusions:

• SET may decrease the expression of key inflammatory markers in PAD patients.
• These anti-inflammatory effects appear to be independent of functional improvements.
• Further research is needed to confirm these findings and assess cardiovascular outcomes.